Letter to the Editor: Effect of Angiotensin Converting Enzyme Inhibitors on Soluble Tumor Necrosis Factor Related Apoptosis‐inducing Ligand Levels ‐ Association with Neointimal Hyperplasia in Drug Eluting Stents

Publisher： John Wiley & Sons Inc

E-ISSN： 1540-8183|28|2|220-221

ISSN： 0896-4327

Source： JOURNAL OF INTERVENTIONAL CARDIOLOGY, Vol.28, Iss.2, 2015-04, pp. : 220-221

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inverse Association of Coronary Soluble Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (sTRAIL) Levels to In-Stent Neointimal Hyperplasia

By  

Cardiology, Vol. 123, Iss. 2, 2012-09 ,pp. : 97-102

Karger

Access to resources Recommend Favorite

Increased hepatotoxicity of tumor necrosis factor–related apoptosis‐inducing ligand in diseased human liver

By  

HEPATOLOGY, Vol. 46, Iss. 5, 2007-11 ,pp. : 1498-1508

John Wiley & Sons Inc

Access to resources Recommend Favorite

Activation of KIT modulates the function of tumor necrosis factor‐related apoptosis‐inducing ligand receptor (TRAIL‐R) in mast cells

By  

ALLERGY, Vol. 70, Iss. 7, 2015-07 ,pp. : 764-774

John Wiley & Sons Inc

Access to resources Recommend Favorite

Apoptotic Phenotype Alters the Capacity of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand to Induce Human Vascular Endothelial Activation

By  

Journal of Vascular Research, Vol. 45, Iss. 2, 2007-10 ,pp. : 111-122

Karger

Access to resources Recommend Favorite

Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation

By Hoffmann Olaf  

Journal of Molecular Medicine, Vol. 87, Iss. 8, 2009-08 ,pp. : 753-763

Springer Publishing Company

Access to resources Recommend Favorite